Biomarkers · Renal & Purine
Beta-2 Microglobulin
Lower values carry lower risk. Not measured in our NHANES panel; the curve is synthesised from the published association.
Hazard ratio relative to the curve's reference value, as synthesised from the published association.
Published hazard ratio2.50top vs bottom quarter (95% CI 1.90–3.28) · NHANES, n=10,388 US adults aged >=20 years, median follow-up 17.9 years (2,780 deaths, general population subset)
Where people sit
Population percentiles (mg/L) by sex and age band. Cycle or source as recorded in the catalogue.
| Sex | Age | 5th | 25th | Median | 75th | 95th | n | Cycle / source |
|---|---|---|---|---|---|---|---|---|
| All | 20-39 | 0.82 | 1.08 | 1.25 | 1.45 | 1.85 | 2,580 | 2017-2018 |
| All | 40-59 | 0.88 | 1.15 | 1.35 | 1.58 | 2.10 | 2,550 | 2017-2018 |
| All | 60+ | 0.95 | 1.28 | 1.50 | 1.78 | 2.35 | 2,670 | 2017-2018 |
| All | all | 0.85 | 1.15 | 1.35 | 1.60 | 2.15 | 7,800 | 2017-2018 |
| Men | all | 0.92 | 1.25 | 1.45 | 1.70 | 2.20 | 3,780 | 2017-2018 |
| Women | all | 0.80 | 1.08 | 1.28 | 1.52 | 2.08 | 4,020 | 2017-2018 |
Sources
- Hazard curve: Synthesized from mortality_association (HR=2.5 quartile_extreme); per-SD log(HR)=0.715. Reported as quartile_extreme HR=2.5 for all-cause mortality. Adjusted HR comparing highest vs lowest quartile of serum beta-2-microglobulin in the gen
- Association of beta-2-microglobulin with cardiovascular and all-cause mortality in the general and non-CKD population. Medicine (Baltimore). 2023;102(11):e33202.